Format

Send to

Choose Destination
Nat Rev Cancer. 2007 Jun;7(6):441-53.

Chronic myeloid leukaemia as a model of disease evolution in human cancer.

Author information

1
Department of Haematology, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. j.melo@imperial.ac.uk

Abstract

Chronic myeloid leukaemia (CML) can be considered as a paradigm for neoplasias that evolve through a multi-step process. CML is also one of the best examples of a disease that can be targeted by molecular therapy; however, the success of new 'designer drugs' is largely restricted to the chronic phase of the disease. If not cured at this stage, CML invariably progresses and transforms into an acute-type leukaemia undergoing a 'blast crisis'. The causes of this transformation are still poorly understood. What mechanisms underlie this progression, and are they shared by other common cancers?

PMID:
17522713
DOI:
10.1038/nrc2147
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center